GEMIN4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.490000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.485200E-01
Normal-vs-Stage2
2.630600E-01
Normal-vs-Stage3
9.749700E-02
Normal-vs-Stage4
5.972200E-01
Stage1-vs-Stage2
4.353000E-01
Stage1-vs-Stage3
5.709900E-02
Stage1-vs-Stage4
9.151200E-01
Stage2-vs-Stage3
1.400250E-01
Stage2-vs-Stage4
5.899200E-01
Stage3-vs-Stage4
3.201900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.728200E-01
Normal-vs-AfricanAmerican
4.771800E-01
Normal-vs-Asian
1.850820E-01
Caucasian-vs-AfricanAmerican
5.798400E-01
Caucasian-vs-Asian
5.849800E-01
AfricanAmerican-vs-Asian
2.812000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.469600E-01
Normal-vs-Female
4.018000E-01
Male-vs-Female
1.613180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.359000E-01
Normal-vs-Age(41-60Yrs)
4.806200E-01
Normal-vs-Age(61-80Yrs)
1.503800E-01
Normal-vs-Age(81-100Yrs)
3.202400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.791000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.254400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.706400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.240830E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.535800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.434200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.746400E-01
Normal-vs-Daily Drinker
7.810000E-02
Normal-vs-Weekly Drinker
7.822200E-01
Normal-vs-Occasional Drinker
3.696400E-01
Normal-vs-Social Drinker
5.301200E-01
Non Drinker-vs-Daily Drinker
6.334800E-01
Non Drinker-vs-Weekly Drinker
3.128800E-01
Non Drinker-vs-Occasional Drinker
2.002600E-01
Non Drinker-vs-Social Drinker
1.169190E-01
Daily Drinker-vs-Weekly Drinker
2.147400E-01
Daily Drinker-vs-Occasional Drinker
6.626500E-02
Daily Drinker-vs-Social Drinker
3.551900E-02
Weekly Drinker-vs-Occasional Drinker
7.339200E-01
Weekly Drinker-vs-Social Drinker
9.147400E-01
Occasional Drinker-vs-Social Drinker
6.746400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.939800E-01
Normal-vs-Grade 2
6.655200E-01
Normal-vs-Grade 3
6.845800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.216000E-01
Grade 1-vs-Grade 3
7.090400E-01
Grade 1-vs-Grade 4
6.939800E-01
Grade 2-vs-Grade 3
2.972600E-01
Grade 2-vs-Grade 4
6.655200E-01
Grade 3-vs-Grade 4
6.845800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.781970E-01
Normal-vs-NonDiabetic
2.563800E-01
Diabetic-vs-NonDiabetic
4.793400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.842400E-01
Normal-vs-NoPancreatitis
2.360800E-01
Pancreatitis-vs-NoPancreatitis
9.833800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.980200E-01
Normal-vs-N1
2.506600E-01
N0-vs-N1
7.471000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.275600E-01
Normal-vs-TP53-NonMutant
7.738400E-01
TP53-Mutant-vs-TP53-NonMutant
1.639000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
